Drawing for Serial No. 79012445

USPTO serial 79012445

Serial No. 79012445

Reviewed by CopyMark Law Group

Reg. 3127143Status 404
Filing date
Status date
Registration date
Aug 8, 2006
Examiner
OLANDRIA, WARREN
Law office
TTAB

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79012445?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan Upton Douglass

SUSAN UPTON DOUGLAS FROSS ZELNICK LEHRMAN & ZISSU PC866 UNITED NATIONS PLAZANEW YORK, NY 10017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, medicines for the treatment of obesity, tobacco withdrawal, and for prevention of cardiovascular diseases; dietetic foods adapted for medical use; beverages for medical use, namely, nutritionally fortified beverages and vitamin fortified beverages; medicinal infusions in the nature of medicinal herbsSECTION 18 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 30, 2015DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Dec 30, 2015DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 21, 2014INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Oct 9, 2013INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Nov 22, 2012INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 21, 2012ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Mar 22, 2012C18.CANCELLED SECTION 18-TOTAL—
Mar 22, 2012CANTCANCELLATION TERMINATED NO. 999999—
Mar 12, 2012CANGCANCELLATION GRANTED NO. 999999—
Feb 7, 2012PETCCANCELLATION INSTITUTED NO. 999999—
Dec 10, 2011ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 18, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 6, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 6, 2007FIMPFINAL DISPOSITION PROCESSED—
Mar 27, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 8, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 16, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 26, 2006NPUBNOTICE OF PUBLICATION—
Mar 27, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 27, 2006ALIEASSIGNED TO LIE—
Mar 4, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 2, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Feb 17, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 17, 2006MAILPAPER RECEIVED—
Jan 19, 2006RFNTREFUSAL PROCESSED BY IB—
Jan 18, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 4, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 25, 2005RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 24, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2005DOCKASSIGNED TO EXAMINER—
Aug 19, 2005NWAPNEW APPLICATION ENTERED—
Aug 18, 2005REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance